Taysha Gene Therapies, Inc. Common Stock Underwriting AgreementUnderwriting Agreement • September 17th, 2020 • Taysha Gene Therapies, Inc. • Biological products, (no disgnostic substances) • New York
Taysha Gene Therapies, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as the representatives (the “Representatives”), an aggregate of [•] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of common stock, par value $[•] per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
TAYSHA GENE THERAPIES, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • September 17th, 2020 • Taysha Gene Therapies, Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of , 20 , and is between Taysha Gene Therapies, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
